DRUGS

of cyclooxygenase (COX)-1. This effect inhibits platelet generation of thromboxane A2,

resulting in an antithrombotic effect.

Intermediate doses (650 mg to 4 g/day) inhibit COX-1 and COX-2, blocking

prostaglandin (PG) production, and have analgesic and antipyretic effects.

High doses (between 4 and 8 g/day) are effective as antiinflammatory agents in

rheumatic disorders; the mechanism(s) of action at these high doses may include both

PG-dependent (particularly COX-2-dependent PGE2) and independent effects


uses 

side effects